Theravance Biopharma Inc (TBPH)
Operating Cash Flow Growth
-104.27%
Quarterly · Period ending:
TBPH Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported-104.27%period ending
Latest reported-104.27%period ending
TBPH Quarterly Cash from Operations YoY % (-32.72% → -104.27%)
Year-over-year change
High-resolution chart · PNG
TBPH operating cash flow growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow Growth |
|---|---|
| -104.2682% | |
| 70.2619% | |
| -572.2838% | |
| -25.2502% | |
| 4,812.8879% | |
| 4,311.2524% | |
| -5.6206% | |
| -109.0105% | |
| 64.4982% | |
| 90.8921% | |
| 99.3116% | |
| 88.7699% | |
| 15.5737% | |
| 56.9565% | |
| -192.3481% | |
| 51.2894% | |
| 70.6064% | |
| 62.6866% | |
| 34.6415% | |
| 41.003% | |
| 6.0604% | |
| -26.7944% | |
| -0.8904% | |
| -72.6301% | |
| -11.0681% | |
| 32.1358% | |
| -23.3317% | |
| 8.8919% | |
| 21.9494% | |
| -262.9563% | |
| -18.0444% | |
| 21.384% | |
| -38.2077% | |
| 199.5982% | |
| -57.2298% | |
| -401.1181% | |
| -38.5561% | |
| -90.1479% | |
| 16.6923% | |
| 61.1293% | |
| 31.0615% | |
| 53.4469% | |
| 20.6704% | |
| 12.0791% | |
| 9.3818% | |
| -26.1501% | |
| -20.8906% | |
| -10.4509% | |
| -111.296% | |
| -57.2391% | |
| -54.9654% | |
| -32.7221% |